目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION AND GEOGRAPHICAL SPREAD
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key sources for secondary research
2.1.1.2 Key objectives of secondary research
2.1.2 PRIMARY DATA
2.1.2.1 Key primary sources
2.1.2.2 Key objectives of primary research
2.1.2.3 Key primary insights
2.1.2.4 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Company revenue estimation approach
2.2.1.2 Customer-based market estimation
2.2.1.3 Growth forecast approach
2.2.1.4 CAGR projections
2.3 DATA TRIANGULATION
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.5.1 PARAMETRIC ASSUMPTIONS
2.5.2 GROWTH RATE ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 JOINT REPLACEMENT DEVICES MARKET OVERVIEW
4.2 NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2024 VS. 2030 (USD MILLION)
4.3 EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE, 2024 VS. 2030 (USD MILLION)
4.4 ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
4.5 GEOGRAPHIC SNAPSHOT OF JOINT REPLACEMENT DEVICES MARKET

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of orthopedic diseases and disorders
5.2.1.2 Increasing demand for minimally invasive surgery
5.2.1.3 Rising adoption of sensor-based implants
5.2.1.4 Rising number of sports injuries
5.2.1.5 Increasing research funding
5.2.2 RESTRAINTS
5.2.2.1 Risks and complications associated with orthopedic surgical procedures
5.2.2.2 Reduced reimbursement rates for orthopedic surgeries
5.2.2.3 High cost of orthopedic surgery
5.2.3 OPPORTUNITIES
5.2.3.1 Advancements in robotic surgery and 3D printing
5.2.3.2 Growth opportunities in emerging markets
5.2.4 CHALLENGES
5.2.4.1 Dearth of skilled orthopedic surgeons
5.3 VALUE CHAIN ANALYSIS
5.3.1 RESEARCH & PRODUCT DEVELOPMENT
5.3.2 RAW MATERIAL PROCUREMENT AND MANUFACTURING
5.3.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
5.4 SUPPLY CHAIN ANALYSIS
5.4.1 MANUFACTURERS
5.4.1.1 Prominent companies
5.4.1.2 Small and medium-sized enterprises
5.4.2 END USERS
5.5 ECOSYSTEM ANALYSIS
5.6 REGULATORY ANALYSIS
5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.6.2 REGULATORY FRAMEWORK
5.6.2.1 North America
5.6.2.1.1 US
5.6.2.1.2 Canada
5.6.2.2 Europe
5.6.2.3 Asia Pacific
5.6.2.3.1 Japan
5.6.2.3.2 China
5.6.2.3.3 India
5.6.2.4 Latin America
5.6.2.4.1 Brazil
5.6.3 REGULATORY APPROVALS
5.7 REIMBURSEMENT SCENARIO
5.8 INVESTMENT AND FUNDING SCENARIO
5.9 PRICING ANALYSIS
5.9.1 AVERAGE SELLING PRICE, BY KEY PLAYER
5.9.2 AVERAGE SELLING PRICE TREND, BY REGION
5.10 TRADE ANALYSIS
5.10.1 IMPORT DATA
5.10.2 EXPORT DATA
5.11 PATENT ANALYSIS
5.12 PORTER'S FIVE FORCES ANALYSIS
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 THREAT OF SUBSTITUTES
5.12.3 BARGAINING POWER OF SUPPLIERS
5.12.4 BARGAINING POWER OF BUYERS
5.12.5 INTENSITY OF COMPETITIVE RIVALRY
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 BUYING CRITERIA
5.14 KEY CONFERENCES AND EVENTS, 2024-2025
5.15 CASE STUDY ANALYSIS
5.15.1 CASE STUDY 1: DIGITAL PLATFORM DESIGNED TO IMPROVE PATIENT CARE PATHWAYS
5.15.2 CASE STUDY 2: PARTIAL KNEE ARTHROPLASTY PERFORMED WITH ROSA PARTIAL KNEE SYSTEM
5.15.3 CASE STUDY 3: ACCURATE DATA GENERATION WITH SHAPEGRABBER 3D
5.16 TECHNOLOGY ANALYSIS
5.16.1 KEY TECHNOLOGIES
5.16.1.1 3D printing/additive manufacturing
5.16.2 COMPLEMENTARY TECHNOLOGIES
5.16.2.1 Robotic orthopedic surgery
5.16.3 ADJACENT TECHNOLOGIES
5.16.3.1 Diagnostic imaging
5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.18 UNMET NEEDS
5.19 IMPACT OF AI ON JOINT REPLACEMENT DEVICES MARKET
5.19.1 KEY USE CASES

6 JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 KNEE REPLACEMENT DEVICES
6.2.1 TOTAL KNEE REPLACEMENT DEVICES
6.2.1.1 Ongoing innovation in knee implants to support market growth
6.2.2 PARTIAL KNEE REPLACEMENT DEVICES
6.2.2.1 Quick recovery and shorter hospital stays to drive segmental growth
6.2.3 REVISION KNEE REPLACEMENT DEVICES
6.2.3.1 Rising incidence of obesity and ongoing technological advancements to fuel growth
6.3 HIP REPLACEMENT DEVICES
6.3.1 TOTAL HIP REPLACEMENT DEVICES
6.3.1.1 Increasing number of hip fractures and increasing success rates of hip arthroplasty to support market
6.3.2 PARTIAL HIP REPLACEMENT DEVICES
6.3.2.1 Increasing geriatric population and rising focus on minimally invasive surgeries to boost market
6.3.3 REVISION HIP REPLACEMENT DEVICES
6.3.3.1 Improved longevity and better patient outcomes to drive growth
6.3.4 HIP RESURFACING DEVICES
6.3.4.1 Improved stability and faster recovery to boost segment
6.4 SHOULDER REPLACEMENT DEVICES MARKET
6.4.1 TOTAL SHOULDER REPLACEMENT DEVICES
6.4.1.1 Increasing launch of new shoulder replacement devices to support market growth
6.4.2 PARTIAL SHOULDER REPLACEMENT DEVICES
6.4.2.1 Growing incidence of rotator cuff disorders to drive growth
6.4.3 REVERSE SHOULDER REPLACEMENT DEVICES
6.4.3.1 Rising number of reverse shoulder arthroplasty procedures to boost market
6.5 ANKLE REPLACEMENT DEVICES
6.5.1 TOTAL ANKLE REPLACEMENT DEVICES
6.5.1.1 Growing number of ankle replacement procedures to fuel uptake
6.5.2 ANKLE FUSION/FIXATION DEVICES
6.5.2.1 Cost-effectiveness and improved surgical outcomes to propel market
6.6 ELBOW REPLACEMENT DEVICES
6.6.1 INCREASING FREQUENCY OF ELBOW JOINT FRACTURES AND GROWTH IN ELDERLY POPULATION TO DRIVE MARKET
6.7 WRIST REPLACEMENT DEVICES
6.7.1 GROWING NUMBER OF WRIST REPLACEMENT PROCEDURES TO DRIVE MARKET GROWTH
6.8 OTHER JOINT REPLACEMENT DEVICES
6.9 BONE GRAFT SUBSTITUTES
6.9.1 COST-EFFECTIVE AND EASY AVAILABILITY OF BONE GRAFT SUBSTITUTES TO PROPEL MARKET

7 JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE
7.1 INTRODUCTION
7.2 TOTAL REPLACEMENT PROCEDURES
7.2.1 INCREASING NUMBER OF HIP AND KNEE REPLACEMENT SURGERIES TO DRIVE MARKET GROWTH
7.3 PARTIAL REPLACEMENT PROCEDURES
7.3.1 INCREASING INCIDENCE OF BONE-RELATED DISORDERS AND QUICKER RECOVERY PERIODS TO BOOST DEMAND
7.4 REVISION REPLACEMENT PROCEDURES
7.4.1 DEVELOPMENT OF SPECIALIZED IMPLANTS TO FUEL DEMAND

8 JOINT REPLACEMENT DEVICES MARKET, BY TYPE
8.1 INTRODUCTION
8.2 CEMENTED FIXATION
8.2.1 RISING NUMBER OF JOINT REPLACEMENT SURGERIES AND DECREASE IN REVISION PROCEDURES TO DRIVE MARKET
8.3 CEMENTLESS FIXATION
8.3.1 IMPROVED STABILITY AND DURABILITY TO FUEL SEGMENT GROWTH
8.4 HYBRID FIXATION
8.4.1 IMPROVED BONE GROWTH AND RAPID RECOVERY TO DRIVE MARKET
8.5 REVERSE HYBRID FIXATION
8.5.1 RISING INCIDENCE OF OSTEOARTHRITIS AND INCREASING NUMBER OF HIP REPLACEMENT SURGERIES TO FUEL MARKET GROWTH

9 JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE
9.1 INTRODUCTION
9.2 TRADITIONAL SURGERY
9.2.1 COST-EFFECTIVENESS AND HIGHER FAMILIARITY TO PROPEL MARKET GROWTH
9.3 MINIMALLY INVASIVE SURGERY
9.3.1 REDUCED PAIN AND FASTER RECOVERY TO DRIVE DEMAND
9.4 COMPUTER-ASSISTED SURGERY
9.4.1 IMPROVED ACCURACY AND REAL-TIME GUIDANCE TO FUEL GROWTH

10 JOINT REPLACEMENT DEVICES MARKET, BY END USER
10.1 INTRODUCTION
10.2 HOSPITALS & SURGICAL CENTERS
10.2.1 RISING NUMBER OF ORTHOPEDIC SURGERIES TO DRIVE MARKET
10.3 AMBULATORY CARE CENTERS & TRAUMA UNITS
10.3.1 COST-EFFECTIVE TREATMENTS OFFERED BY AMBULATORY CARE CENTERS TO PROPEL MARKET GROWTH
10.4 ORTHOPEDIC CLINICS
10.4.1 RISING NUMBER OF ORTHOPEDIC CLINICS TO SUPPORT MARKET GROWTH

11 JOINT REPLACEMENT DEVICES MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.2.2 US
11.2.2.1 Growing focus on launching technologically advanced hybrid implants to drive market
11.2.3 CANADA
11.2.3.1 Rising incidence of degenerative bone diseases to support market growth
11.3 EUROPE
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
11.3.2 GERMANY
11.3.2.1 Increasing focus on commercialization of joint replacement devices to boost demand
11.3.3 FRANCE
11.3.3.1 Increasing cases of obesity and subsequent rise in osteoporosis to drive market
11.3.4 UK
11.3.4.1 Increasing awareness of orthopedic conditions to boost demand
11.3.5 ITALY
11.3.5.1 Growing focus on preventive care for musculoskeletal injuries to drive market
11.3.6 SPAIN
11.3.6.1 Rising preference for MIS techniques to support market growth
11.3.7 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.4.2 JAPAN
11.4.2.1 Rapidly growing geriatric population to propel market
11.4.3 CHINA
11.4.3.1 Expanding target patient population to drive market
11.4.4 INDIA
11.4.4.1 Increasing number of hospitals adopting robotic-assisted joint replacement surgery to support market growth
11.4.5 AUSTRALIA
11.4.5.1 Favorable government initiatives for bone health awareness to fuel market
11.4.6 SOUTH KOREA
11.4.6.1 Favorable government support for healthcare access to support market growth
11.4.7 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.5.2 BRAZIL
11.5.2.1 Expansion of global market players for advanced product commercialization to boost demand
11.5.3 MEXICO
11.5.3.1 Favorable investments for medical device manufacturers to support market growth
11.5.4 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
11.6.2 GCC COUNTRIES
11.6.2.1 Rising focus on in-house manufacturing of advanced orthopedic devices to support market growth
11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021-2024
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN JOINT REPLACEMENT DEVICES MARKET
12.3 REVENUE ANALYSIS, 2019-2023
12.4 MARKET SHARE ANALYSIS, 2023
12.5 COMPANY VALUATION AND FINANCIAL METRICS
12.6 BRAND/PRODUCT COMPARISON
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
12.7.1 STARS
12.7.2 EMERGING LEADERS
12.7.3 PERVASIVE PLAYERS
12.7.4 PARTICIPANTS
12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
12.7.5.1 Company footprint
12.7.5.2 Region footprint
12.7.5.3 Type footprint
12.7.5.4 Surgery type footprint
12.7.5.5 Type footprint
12.7.5.6 Technique footprint
12.7.5.7 End-user footprint
12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
12.8.1 PROGRESSIVE COMPANIES
12.8.2 RESPONSIVE COMPANIES
12.8.3 DYNAMIC COMPANIES
12.8.4 STARTING BLOCKS
12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
12.8.5.1 Detailed list of key startups/SMEs
12.8.5.2 Competitive benchmarking of startups/SMEs
12.9 COMPETITIVE SCENARIO
12.9.1 PRODUCT LAUNCHES AND APPROVALS
12.9.2 DEALS
12.9.3 EXPANSIONS

13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 ZIMMER BIOMET
13.1.1.1 Business overview
13.1.1.2 Products offered
13.1.1.3 Recent developments
13.1.1.3.1 Product launches and approvals
13.1.1.3.2 Deals
13.1.1.4 MnM view
13.1.1.4.1 Key strengths
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses and competitive threats
13.1.2 STRYKER
13.1.2.1 Business overview
13.1.2.2 Products offered
13.1.2.3 Recent developments
13.1.2.3.1 Product launches and approvals
13.1.2.3.2 Deals
13.1.2.3.3 Expansions
13.1.2.4 MnM view
13.1.2.4.1 Right to win
13.1.2.4.2 Strategic choices
13.1.2.4.3 Weaknesses and competitive threats
13.1.3 JOHNSON & JOHNSON MEDTECH
13.1.3.1 Business overview
13.1.3.2 Products offered
13.1.3.3 Recent developments
13.1.3.3.1 Product launches and approvals
13.1.3.3.2 Deals
13.1.3.4 MnM view
13.1.3.4.1 Right to win
13.1.3.4.2 Strategic choices
13.1.3.4.3 Weaknesses and competitive threats
13.1.4 SMITH+NEPHEW
13.1.4.1 Business overview
13.1.4.2 Products offered
13.1.4.3 Recent developments
13.1.4.3.1 Product launches and approvals
13.1.4.3.2 Deals
13.1.4.3.3 Expansions
13.1.4.4 MnM view
13.1.4.4.1 Key strengths
13.1.4.4.2 Strategic choices
13.1.4.4.3 Weaknesses and competitive threats
13.1.5 B. BRAUN
13.1.5.1 Business overview
13.1.5.2 Products offered
13.1.5.3 MnM view
13.1.5.3.1 Right to win
13.1.5.3.2 Strategic choices
13.1.5.3.3 Weaknesses and competitive threats
13.1.6 GLOBUS MEDICAL
13.1.6.1 Business overview
13.1.6.2 Products offered
13.1.6.3 Recent developments
13.1.6.3.1 Product launches and approvals
13.1.6.3.2 Deals
13.1.7 ARTHREX, INC.
13.1.7.1 Business overview
13.1.7.2 Products offered
13.1.8 ENOVIS
13.1.8.1 Business overview
13.1.8.2 Products offered
13.1.8.3 Recent developments
13.1.8.3.1 Product launches and approvals
13.1.8.3.2 Deals
13.1.8.3.3 Expansions
13.1.9 ACUMED LLC
13.1.9.1 Business overview
13.1.9.2 Products offered
13.1.9.3 Recent developments
13.1.9.3.1 Product launches and approvals
13.1.9.3.2 Deals
13.1.9.3.3 Expansions
13.1.10 ORTHOFIX MEDICAL INC.
13.1.10.1 Business overview
13.1.10.2 Products offered
13.1.10.3 Recent developments
13.1.10.3.1 Product launches and approvals
13.1.10.3.2 Deals
13.1.11 MICROPORT SCIENTIFIC CORPORATION
13.1.11.1 Business overview
13.1.11.2 Products offered
13.1.11.3 Recent developments
13.1.11.3.1 Product launches and approvals
13.1.11.3.2 Deals
13.1.12 CONMED CORPORATION
13.1.12.1 Business overview
13.1.12.2 Products offered
13.1.12.3 Recent developments
13.1.12.3.1 Deals
13.1.13 MEDACTA INTERNATIONAL
13.1.13.1 Business overview
13.1.13.2 Products offered
13.1.13.3 Recent developments
13.1.13.3.1 Product launches and approvals
13.1.13.3.2 Deals
13.1.13.3.3 Expansions
13.1.14 PARAGON 28, INC.
13.1.14.1 Business overview
13.1.14.2 Products offered
13.1.14.3 Recent developments
13.1.14.3.1 Product launches and approvals
13.1.14.3.2 Deals
13.1.15 MERIL LIFE SCIENCES PVT. LTD.
13.1.15.1 Business overview
13.1.15.2 Products offered
13.1.15.3 Recent developments
13.1.15.3.1 Expansions
13.1.16 GPC MEDICAL LTD.
13.1.16.1 Business overview
13.1.16.2 Products offered
13.1.17 MAXX ORTHOPEDICS, INC.
13.1.17.1 Business overview
13.1.17.2 Products offered
13.1.17.3 Recent developments
13.1.17.3.1 Product launches and approvals
13.1.17.3.2 Deals
13.1.18 AUXEIN
13.1.18.1 Business overview
13.1.18.2 Products offered
13.1.18.3 Recent developments
13.1.18.3.1 Deals
13.1.19 NORAKER
13.1.19.1 Business overview
13.1.19.2 Products offered
13.1.19.3 Recent developments
13.1.19.3.1 Product launches and approvals
13.1.19.3.2 Deals
13.1.20 NEXTSTEP ARTHROPEDIX
13.1.20.1 Business overview
13.1.20.2 Products offered
13.1.21 EXACTECH, INC.
13.1.21.1 Business overview
13.1.21.2 Products offered
13.1.21.3 Recent developments
13.1.21.3.1 Product launches and approvals
13.1.21.3.2 Deals
13.2 OTHER PLAYERS
13.2.1 FH ORTHO
13.2.2 SYMBIOS ORTHOPEDIE S.A.
13.2.3 MADISON ORTHO
13.2.4 GREEN SURGICALS PVT. LTD.
13.2.5 SIORA SURGICAL PVT. LTD.
13.2.6 ORTHOPEDIATRICS CORP.
13.2.7 RESTOR3D
13.2.8 DOUBLE MEDICAL TECHNOLOGY INC.
13.2.9 TREACE MEDICAL CONCEPTS, INC.
13.2.10 AK MEDICAL

14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS